Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance

Neuroblastoma is the most common extracranial solid tumour in children, accounting for 15% of all paediatric cancer deaths. High-risk neuroblastoma is a particularly challenging-to-treat form of disease that requires multimodality treatment, consisting of chemotherapy, surgery, high-dose chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Barone, Giuseppe, Barry, Ailish, Bautista, Francisco, Brichard, Bénédicte, Defachelles, Anne-Sophie, Herd, Fiona, Manzitti, Carla, Reinhardt, Dirk, Rubio, Pedro M., Wieczorek, Aleksandra, van Noesel, Max M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Therapy in Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563639/
https://www.ncbi.nlm.nih.gov/pubmed/34541620
http://dx.doi.org/10.1007/s40272-021-00469-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563639/
https://www.ncbi.nlm.nih.gov/pubmed/34541620
http://dx.doi.org/10.1007/s40272-021-00469-9

Ejemplares similares